fluoxetine and rivastigmine

fluoxetine has been researched along with rivastigmine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Feng, F; He, S; Jiang, H; Jiang, X; Liu, W; Qu, W; Sun, H; Zhou, J	1
Borhani Haghighi, A; Haghshenas, H; Mosavinasab, M; Mowla, A	1

Reviews

3 review(s) available for fluoxetine and rivastigmine

Article	Year
Multi-target-directed ligands to combat neurodegenerative diseases. Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid	2008
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. Journal of medicinal chemistry, 2019, 10-24, Volume: 62, Issue:20 Topics: Animals; Drug Combinations; Drug Delivery Systems; Drug Design; Humans; Ligands	2019

Trials

1 trial(s) available for fluoxetine and rivastigmine

Article	Year
Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Phenylcarbamates; Psychiatric Status Rating Scales; Psychometrics; Rivastigmine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2007

Article

Year

Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial.

Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5

Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Phenylcarbamates; Psychiatric Status Rating Scales; Psychometrics; Rivastigmine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index

2007